CA2328250A1 - Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4) - Google Patents

Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4) Download PDF

Info

Publication number
CA2328250A1
CA2328250A1 CA002328250A CA2328250A CA2328250A1 CA 2328250 A1 CA2328250 A1 CA 2328250A1 CA 002328250 A CA002328250 A CA 002328250A CA 2328250 A CA2328250 A CA 2328250A CA 2328250 A1 CA2328250 A1 CA 2328250A1
Authority
CA
Canada
Prior art keywords
nr10c
substituted
cr4r5
alkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002328250A
Other languages
English (en)
Inventor
Cornelia Jutta Forster
Siegfried Benjamin Christensen Iv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2328250A1 publication Critical patent/CA2328250A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/47—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne des cétones, alcools et amines, représentés par les analogues d'une 3-(3-cyclopentyloxy-4-méthoxyphényl)-3-phényléthynylcyclobutan-1-one, et utiles en tant qu'antagonistes de PDE 4.
CA002328250A 1998-04-14 1999-04-13 Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4) Abandoned CA2328250A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8170298P 1998-04-14 1998-04-14
US60/081,702 1998-04-14
PCT/US1999/007995 WO1999052847A1 (fr) 1998-04-14 1999-04-13 Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4)

Publications (1)

Publication Number Publication Date
CA2328250A1 true CA2328250A1 (fr) 1999-10-21

Family

ID=22165846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328250A Abandoned CA2328250A1 (fr) 1998-04-14 1999-04-13 Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4)

Country Status (4)

Country Link
EP (1) EP1071645A4 (fr)
JP (1) JP2002511438A (fr)
CA (1) CA2328250A1 (fr)
WO (1) WO1999052847A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345405A (en) * 1964-03-31 1967-10-03 Smith Kline French Lab 1-amino-2(and 3)-phenylcyclobutane-1-carboxylic acids
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity
TW332201B (en) * 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives

Also Published As

Publication number Publication date
WO1999052847A1 (fr) 1999-10-21
EP1071645A1 (fr) 2001-01-31
JP2002511438A (ja) 2002-04-16
EP1071645A4 (fr) 2003-04-02

Similar Documents

Publication Publication Date Title
US5723681A (en) 3,3-(disubstituted)cyclohexan-1-01 dimers and related compounds
US5990119A (en) 1,4,4-(trisubstituted)cyclohexane monomers and related compounds
US6172118B1 (en) Compounds
US5646158A (en) 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
AU711101B2 (en) 3,3-(disubstituted)cyclohexan-1-OL monomers and related compounds
US5767151A (en) 3,3-(disubstituted) cyclohexan-1-ylidine acetate dimers and related compounds
CA2328250A1 (fr) Composes inhibant l'isoenzyme phosphodiesterase 4 (pde 4)
WO1996020159A1 (fr) Monomeres d'acetate 3,3-hexamethylene (bisubstitue)-1-ylidine et composes connexes
EP0799205B1 (fr) Monomeres de 1,4,4-(trisubstitue)cyclohex-1-ene utilises comme inhibiteurs de pde iv et tnf
US5777176A (en) 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
WO1996020160A1 (fr) Dimeres 1,3,3-(trisubstitues)cyclohexane et composes apparentes
US5900417A (en) 1,3,3-(Trisubstituted)cyclohexanemonomers and related compounds
EP0799036A1 (fr) Dimeres d'acetate 4,4-(disubstitue)cyclohexane-1-ylidine et composes associes
EP0799204A1 (fr) Monomeres de 1,3,3-(trisubstitue)cyclohexane et composes apparentes
EP0801566A1 (fr) Monomeres de 4,4-(disubstitue)cyclohexan-1-ylidine acetate et composes apparentes
WO1996019994A1 (fr) Monomeres 3,3-(disubstitues) cyclohexan-1-carboxylate et composes correspondants
WO1996019979A1 (fr) Dimeres de 1,4,4-(trisubstitue)cyclohexane et composes apparentes
EP0802791A1 (fr) Dimeres de 3,3-(disubstitues)cyclohexan-1-ylidine acetate et composes correspondants
EP0794773A1 (fr) Monomeres de 1,4,4-(trisubstitue) cyclohexane et composes apparentes

Legal Events

Date Code Title Description
FZDE Dead